Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In this chapter, I summarize current knowledge regarding the mechanisms by which infected cells and the immune system control HCV replication and spread, and how HCV infection persists despite targeting by innate antiviral mechanisms and the adaptive immune system. Recognition of viral RNA stimulates infected cells to produce interferons, which are potent antiviral mediators, but HCV proteins may disable RNA recognition and interferon response mechanisms. Spontaneous HCV clearance is associated with a broadly focused and robust HCV-specific T cell response. However, T cell mediated control of HCV is frequently hampered by viral sequence evolution, exhaustion of HCV-specific T cells, and tolerance mechanisms that protect the liver from immunologically mediated pathology. HCV-specific antibodies can limit but not completely ablate HCV infection of new target cells. As for T cell responses, the efficacy of antibody responses may be limited by viral evolution. Interferons and some soon-to-be available antiviral drugs may enhance innate and adaptive immune mechanisms.



Book title

HCV Infection and Cryoglobulinemia



Publication Date



21 - 36

Total pages